Pacific Biosciences of California, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -22.9% | -10.7% | -9.0% |
| FY2022 | -55.8% | -21.5% | -17.8% |
| FY2023 | -43.7% | -43.7% | -17.6% |
| FY2024 | -61.2% | -61.2% | -24.6% |
| FY2025 | -10,214.5% | -10,214.5% | -69.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -22.9% | -10.7% | -9.0% |
| FY2022 | -55.8% | -21.5% | -17.8% |
| FY2023 | -43.7% | -43.7% | -17.6% |
| FY2024 | -61.2% | -61.2% | -24.6% |
| FY2025 | -10,214.5% | -10,214.5% | -69.7% |